Postdoc Position in Clinical Bioinformatics for Breast Cancer Precision Oncology

 

Department: Molecular Precision Oncology Program

Code number: 2022-0075

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

The National Center of Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital and the German Cancer Aid. The NCT with sites in Heidelberg and Dresden is the leading oncological center in Germany and shall be expanded to an international center of excellence regarding point-of-care and individualised cancer medicine.

Within a clinical trial at the NCT Heidelberg and the DKFZ we offer a position for a translational bioinformatician. The position will be situated in the Molecular Precision Oncology Program at DKFZ in Heidelberg, Germany in a large campus housing also the University Hospital as well as other University departments and research institutes.

You will work in an interdisciplinary team of bioinformaticians, molecular biologists and clinicians to identify targetable lesions and recommend targeted treatments for breast cancer patients.

Job description:

The bioinformatician will work together with experienced translational bioinformaticians and clinicians to analyse whole genome and transcriptome sequencing data of breast cancer patients. The analysis results will improve personalized treatment recommendations that will be discussed in weekly tumor boards at the NCT Heidelberg on campus. Furthermore, the applicant is expected to improve already-established analysis pipelines and to develop own workflows supporting clinically relevant interpretation of the next generation sequencing data. In addition, the applicant will have the opportunity to develop own research projects in collaboration with the experimental groups within the division.

Requirements:

Bioinformatician with a master's degree, a Ph.D. is preferred. Experience in the analysis of next generation sequencing data, ideally in a clinical context interpreting actionable mutations. Knowledge of breast cancer biology and cancer drugs is an advantage. Working language is English. Experience in quality management is an advantage.

We offer:

• Interesting, versatile workplace
• International, attractive working environment
• Campus with modern state-of-the-art infrastructure
• Salary according to TV-L including social benefits
• Possibility to work part-time
• Flexible working hours
• Comprehensive further training program
• Access to the DKFZ  International Postdoc Program

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles as well as against COVID-19 may work at the DKFZ.

Earliest possible start date: 01.05.2022

Duration: The position is initially limited to 2 years. ​

The position can in principle be part-time.

Application deadline: 18.03.2022

Contact:

Andrea Stephani
Phone +49 6221/42-1608

Please note that we do not accept applications submitted via email.

---

The DKFZ is committed to increase the proportion of women in all areas and 

positions in which women are underrepresented. Qualified female applicants 

are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities 

will be given preference.

To apply for a position please use our online application 

portal (https://www.dkfz.de/en/stellenangebote/index.php).

We ask for your understanding that we cannot return application documents that 

are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung,

 Im Neuenheimer Feld 280, 69120 Heidelberg) and that we do not accept 

applications submitted via email. We apologize for any inconvenience this may cause.

Apply